Comparison

MPT0B014 European Partner

Item no. HY-120786-10mg
Manufacturer MedChem Express
CASRN 1215208-59-5
Amount 10 mg
Category
Type Inhibitors
Specific against other
Purity 99.67
Formula C19H17NO4
Citations [1]Tsai AC, et al. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells. Br J Pharmacol. 2014 Jan;171(1):122-33.
Smiles O=C(C1=CC=C2N=CC=CC2=C1)C3=CC(OC)=C(OC)C(OC)=C3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 6-(3′,4′,5′-Trimethoxybenzoyl)quinoline
Available
Product Description
MPT0B014 is a tubulin polymerization inhibitor. MPT0B014 induces cancer cell apoptosis. MPT0B014 can be used for the research of cancer[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
MolecularWeight
323.34
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 50 mg/mL (ultrasonic)
Manufacturers Target
Apoptosis; Microtubule/Tubulin
Pathway
Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close